| |
| |
|
| Insider
Information: |
Freund John Gordon |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
2,248,476 |
|
|
Indirect Shares
|
9,013,510 |
|
|
| Direct
Value |
$8,758,006 |
|
|
|
Indirect Value
|
$20,839,496 |
|
|
| Total
Shares |
11,261,986 |
|
|
| Total
Value |
$29,597,502 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 257.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenoport Inc |
XNPT |
Director |
2016-07-05 |
0 |
2016-07-05 |
0 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2006-11-21 |
0 |
2009-04-17 |
2,000,936 |
Premium* |
|
|
Map Pharmaceuticals Inc |
MAPP |
Director, 10% Owner |
2011-02-14 |
1,984 |
2011-05-20 |
5,152 |
Premium* |
|
|
Mako Surgical Corp. |
MAKO |
Director |
|
0 |
2013-12-17 |
0 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
10% Owner |
2011-02-16 |
0 |
2012-05-29 |
4,161,933 |
Premium* |
|
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director |
2019-12-10 |
0 |
2019-12-10 |
0 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director, 10% Owner |
|
0 |
2014-02-20 |
1,208,920 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
Director |
2019-11-08 |
2,175,882 |
2014-10-27 |
1,432,930 |
Premium* |
|
|
Collegium Pharmaceutical, Inc |
COLL |
Director |
2023-05-18 |
44,775 |
2023-05-18 |
43,413 |
Premium* |
|
|
Sutro Biopharma Inc |
STRO |
Director |
2018-10-01 |
0 |
2020-12-10 |
56,327 |
Premium* |
|
|
Si-Bone, Inc. |
SIBN |
|
2023-08-09 |
25,835 |
2023-08-09 |
103,899 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MAKO |
Mako Surgical Corp. |
10% Owner |
– – • |
2008-10-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,437,249 |
|
- |
|
| MAKO |
Mako Surgical Corp. |
Director |
– • – |
2008-10-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,437,249 |
|
- |
|
| TTPH |
Tetraphase Pharmaceutical... |
Director |
– • • |
2013-03-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,345 |
|
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • • |
2014-02-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
32,372 |
|
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2005-09-02 |
4 |
B |
$13.00 |
$10,725 |
I/I |
825 |
1,098,184 |
2.1 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2005-09-06 |
4 |
B |
$13.00 |
$9,035 |
I/I |
695 |
1,098,879 |
2.1 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2005-09-07 |
4 |
B |
$13.00 |
$97,471 |
I/I |
7,480 |
1,106,359 |
2.1 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2005-09-13 |
4 |
B |
$15.07 |
$63,524 |
I/I |
4,200 |
1,110,559 |
2.1 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2006-11-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(271,546) |
825,813 |
0 |
- |
|
| HNSN |
Hansen Medical Inc |
Director |
– • – |
2006-11-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,318,787 |
170,909 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2007-04-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(120,644) |
705,169 |
0 |
- |
|
| HNSN |
Hansen Medical Inc |
Director |
– • – |
2007-05-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(386,954) |
1,754,203 |
0 |
- |
|
| HNSN |
Hansen Medical Inc |
Director |
– • – |
2007-05-21 |
4 |
A |
$0.00 |
$0 |
I/I |
3,729 |
3,552 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2007-10-05 |
4 |
B |
$12.00 |
$999,996 |
I/I |
83,333 |
83,333 |
2.1 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2007-10-11 |
4 |
A |
$14.50 |
$1,868,757 |
I/I |
128,862 |
212,195 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2007-10-11 |
4 |
OE |
$14.50 |
$23,765,834 |
I/I |
1,638,797 |
1,850,992 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2008-03-14 |
4 |
B |
$41.43 |
$112,690 |
D/D |
2,720 |
2,720 |
2.39 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2008-03-14 |
4 |
B |
$41.24 |
$202,619 |
I/I |
4,858 |
18,058 |
2.1 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2008-05-09 |
4 |
B |
$40.35 |
$4,411,286 |
I/I |
109,325 |
814,249 |
2.1 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2008-05-12 |
4 |
B |
$43.23 |
$6,354,774 |
I/I |
147,008 |
961,257 |
2.1 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2008-05-13 |
4 |
B |
$43.59 |
$4,228,065 |
I/I |
97,000 |
1,058,257 |
2.1 |
- |
|
| HNSN |
Hansen Medical Inc |
Director |
– • – |
2009-04-17 |
4 |
B |
$3.25 |
$1,250,002 |
I/I |
384,616 |
2,000,936 |
2.1 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2009-07-08 |
4 |
B |
$19.00 |
$2,470,000 |
I/I |
130,000 |
1,188,257 |
2.1 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2009-07-10 |
4 |
B |
$18.95 |
$95,081 |
I/I |
5,000 |
6,200 |
2.1 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Director |
– • – |
2009-08-06 |
4 |
B |
$9.70 |
$1,999,995 |
I/I |
206,185 |
45,980 |
2.1 |
- |
|
140 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
